You likely have clinical validation... not scalable adoption. In Medical AI, pilots prove performance. Scaling depends on structural alignment: 1. Economic Buyer Doctors liking it is insufficient. If the budget holder (hospital admin, procurement, payer) doesn’t see direct ROI, adoption stalls. 2. Incentive Structure If reimbursement is unclear or financial upside isn’t explicit, usage plateaus after pilots. 3. Workflow Friction Any added complexity in EHR/PACS integration or clinical workflow reduces expansion velocity. 4. Sales Repeatability Pilot success is often founder-driven. Scaling requires a standardized, multi-stakeholder enterprise sales motion. In short: You solved for accuracy. You haven’t fully solved for institutional economics and distribution.

re deciding between validation capital (Kickstarter) and growth capital (Equity). If your main risk is demand uncertainty, Kickstarter can validate the market while funding initial production. If your main constraint is capital intensity (tooling, certifications, inventory, working capital), equity may be more appropriate. For hardware in the UK B2C space, production readiness and certification timing are critical. Crowdfunding works best when operational risk is already minimized. The decision should be driven by risk profile, not preference.